METABOLIC BRAIN DISEASE

Scope & Guideline

Unraveling the complexities of brain health and disease.

Introduction

Explore the comprehensive scope of METABOLIC BRAIN DISEASE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore METABOLIC BRAIN DISEASE in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0885-7490
PublisherSPRINGER/PLENUM PUBLISHERS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1986 to 2024
AbbreviationMETAB BRAIN DIS / Metab. Brain Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address233 SPRING ST, NEW YORK, NY 10013

Aims and Scopes

The journal 'Metabolic Brain Disease' focuses on the interplay between metabolic processes and neurological health, exploring how metabolic dysfunctions can lead to brain diseases. It aims to disseminate research findings that connect metabolic pathways with neurodegenerative and psychiatric disorders, employing a variety of methodologies including molecular biology, biochemistry, and clinical studies.
  1. Metabolic Dysfunction and Neurological Disorders:
    The journal emphasizes research on how metabolic disorders, such as diabetes and obesity, contribute to the pathogenesis of various neurological diseases, including Alzheimer's, Parkinson's, and multiple sclerosis.
  2. Neuroinflammation and Oxidative Stress:
    It explores the role of neuroinflammation and oxidative stress in brain disorders, focusing on their contributions to neuronal damage and cognitive decline.
  3. Therapeutic Approaches and Drug Development:
    Research on novel pharmacological and non-pharmacological interventions, including natural compounds and lifestyle modifications, aimed at mitigating metabolic and neurological disorders is a core focus.
  4. Molecular and Genetic Mechanisms:
    The journal publishes studies that investigate the molecular and genetic underpinnings of brain diseases, including the role of non-coding RNAs and metabolic enzymes.
  5. Animal Models and Clinical Studies:
    Utilizing both experimental animal models and clinical studies, the journal aims to bridge the gap between laboratory research and therapeutic applications in humans.
Recent publications in 'Metabolic Brain Disease' demonstrate a clear evolution in research themes, highlighting emerging trends that are becoming increasingly relevant in the context of neurological health and metabolic interactions.
  1. Gut-Brain Axis Research:
    An increasing number of studies are investigating the gut-brain connection, particularly how gut microbiota and metabolites influence neurological disorders and cognitive functions.
  2. Network Pharmacology and Integrative Approaches:
    The use of network pharmacology and integrative approaches to drug discovery is on the rise, reflecting a shift towards understanding the multi-target effects of therapies rather than focusing on single molecules.
  3. Neuroprotective Natural Compounds:
    There is a growing interest in the neuroprotective properties of natural compounds, with many studies exploring how dietary components and herbal extracts can prevent or mitigate brain disorders.
  4. MicroRNA and Epigenetics:
    Research focusing on the role of microRNAs and epigenetic modifications in metabolic and neurological diseases is trending, emphasizing their potential as biomarkers and therapeutic targets.
  5. Exercise and Lifestyle Interventions:
    An emerging focus on the effects of physical activity and lifestyle changes on brain health is evident, with studies documenting how exercise can influence cognitive function and metabolic health.

Declining or Waning

While 'Metabolic Brain Disease' continues to expand into new areas of research, some traditional themes are showing signs of decline. These waning scopes reflect shifts in research priorities and emerging interests in the field.
  1. Traditional Drug Development Approaches:
    There is a noticeable decrease in publications focusing solely on conventional pharmacological approaches, as research shifts towards integrative and holistic treatment strategies.
  2. Basic Neuroanatomy Studies:
    Research that primarily focuses on basic neuroanatomical studies without linking to metabolic or pathological conditions has become less prominent, indicating a shift towards more clinically relevant investigations.
  3. Single-Factor Studies:
    Studies examining single metabolic factors in isolation are declining, as there is a growing preference for comprehensive, multi-factorial approaches that consider the interplay of various metabolic and neurological factors.

Similar Journals

BIOFACTORS

Bridging Laboratory Discoveries with Clinical Excellence
Publisher: WILEYISSN: 0951-6433Frequency: 6 issues/year

BIOFACTORS, an esteemed journal published by Wiley, serves as a pivotal resource in the fields of Biochemistry, Clinical Biochemistry, and Molecular Medicine. With ISSN 0951-6433 and E-ISSN 1872-8081, the journal has established its reputation since its inception in 1988, showcasing a rich history of scientific inquiry and innovation. Recognized for its high academic standards, it currently holds a Q1 ranking in key categories, including Biochemistry and Medicine (miscellaneous), and ranks in the top 10% for Clinical Biochemistry according to Scopus metrics, reflecting its impact and influence in the scientific community. Although it does not offer Open Access, BIOFACTORS provides researchers the opportunity to publish and disseminate high-quality studies that advance our understanding of biological factors and their clinical implications. The journal actively encourages contributions that bridge the gap between laboratory findings and clinical applications, making it a vital platform for both seasoned researchers and emerging scholars in the life sciences.

Frontiers in Aging Neuroscience

Bridging Science and Aging for Cognitive Excellence.
Publisher: FRONTIERS MEDIA SAISSN: 1663-4365Frequency: 1 issue/year

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

NeuroImage-Clinical

Connecting Researchers and Clinicians in Neuroimaging Excellence
Publisher: ELSEVIER SCI LTDISSN: 2213-1582Frequency:

NeuroImage-Clinical is a premier open access journal published by Elsevier Science Ltd, dedicated to advancing the field of clinical neuroimaging and its applications in a variety of neurological disorders. With an ISSN of 2213-1582, this journal has established itself as a leading source of innovative research since its inception in 2012, now continuing through 2024. Recognized for its high impact, it occupies the top quartile (Q1) in prestigious categories such as Cognitive Neuroscience, Neurology, and Radiology, affirming its relevance in clinical and research settings. Its Scopus rankings further exemplify its significant contribution to the disciplines of Radiology and Neurology, consistently placing it among the top tiers of journals in these fields. This journal not only provides critical insights for researchers and professionals but also serves as a valuable resource for students, fostering an understanding of the complexities in neuroimaging techniques and their implications for patient care. With open access options ensuring broad dissemination of knowledge, NeuroImage-Clinical plays a pivotal role in enhancing collaboration and innovation within the global neuroscience community.

NEUROPATHOLOGY

Unraveling the Complexities of Brain Pathology
Publisher: WILEYISSN: 0919-6544Frequency: 6 issues/year

NEUROPATHOLOGY, an esteemed journal published by WILEY, is a pivotal platform in the fields of medicine and neurology, focusing on the intricate relationship between pathology and neurological disorders. Established in 1993 and continually evolving until 2024, the journal holds a notable presence within the academic community, as evidenced by its current Q2 ranking in several categories including Medicine (Miscellaneous), Neurology (Clinical), and Pathology and Forensic Medicine. With a Scopus ranking placing it within the top 30% of its field, NEUROPATHOLOGY serves as a vital resource for researchers, healthcare professionals, and students dedicated to advancing their knowledge of neuropathological processes. Although not an Open Access journal, it ensures accessibility to cutting-edge research and insights that shape contemporary understanding and clinical practice. Its robust impact factor underscores the journal's critical role in disseminating innovative findings within the realms of neurology and pathology, making it an essential read for those at the forefront of medical research.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Pioneering Research for a Healthier Tomorrow
Publisher: TAYLOR & FRANCIS LTDISSN: 1381-3455Frequency: 5 issues/year

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

Molecular Brain

Advancing Knowledge in the Molecular Mechanisms of the Brain
Publisher: BMCISSN: Frequency: 1 issue/year

Molecular Brain is a prestigious open-access journal published by BMC, dedicated to advancing the field of neuroscience with a particular focus on cellular and molecular mechanisms. Since its inception in 2008, the journal has been committed to disseminating high-quality research that explores the intricate workings of the brain, particularly in areas related to cellular and molecular neuroscience. Located in the heart of London, England, Molecular Brain has garnered significant recognition in the academic community, boasting a 2023 categorization in the Q2 quartile for both Cellular and Molecular Neuroscience and Molecular Biology, reflecting its growing influence and relevance in these fields. With its Scopus ranks placing it in the top 32% and 38% of its respective categories, the journal serves as an essential platform for researchers, professionals, and students alike, encouraging collaboration and knowledge-sharing through its accessible online format.

BRAIN BEHAVIOR AND IMMUNITY

Exploring the Nexus of Neuroscience and Immunology.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0889-1591Frequency: 8 issues/year

BRAIN BEHAVIOR AND IMMUNITY is a premier academic journal published by ACADEMIC PRESS INC ELSEVIER SCIENCE, focusing on the intricate relationships between the nervous and immune systems. With an impressive impact factor and consistent ranking in the top quartile (Q1) across several categories such as Behavioral Neuroscience, Endocrine and Autonomic Systems, and Immunology, this journal stands out as a critical resource for researchers and professionals in these rapidly evolving fields. Since its inception in 1987, the journal has committed to publishing high-quality, peer-reviewed research that advances our understanding of immunological processes as they relate to behavior and mental health. Though it does not currently offer Open Access, it is widely accessible to institutional libraries and professionals, ensuring that groundbreaking research reaches a broad audience. As the field continues to expand, BRAIN BEHAVIOR AND IMMUNITY remains a vital platform for innovative studies and reviews that bridge the gap between neuroscience and immunology, making it an essential read for academics, clinicians, and students dedicated to furthering research in this interdisciplinary domain.

STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS

Pioneering Research in the Biology of Stress
Publisher: TAYLOR & FRANCIS LTDISSN: 1025-3890Frequency: 6 issues/year

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

Championing Pioneering Studies in Trace Elements and Biological Systems
Publisher: ELSEVIER GMBHISSN: 0946-672XFrequency: 6 issues/year

The JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, published by Elsevier GmbH, stands as a leading platform for disseminating pivotal research in the interdisciplinary field that bridges biochemistry, inorganic chemistry, and molecular medicine. With an impact factor reflective of its high-quality submissions and significant contribution to the scientific community, this journal currently holds a Q2 ranking in Biochemistry and a Q1 ranking in Inorganic Chemistry, underlining its esteemed status among peers. Since its inception in 1995 and continuing through to 2024, the journal has fostered a dynamic discourse on the fundamental roles of trace elements in biological systems, incorporating studies that range from their biochemical functions to their impact on health and disease. Researchers, professionals, and students alike can access a wealth of knowledge, missing Open Access options notwithstanding, making it indispensable for those at the forefront of scientific investigation in medicine and biology.

Egyptian Journal of Neurology Psychiatry and Neurosurgery

Illuminating Pathways in Neurology, Psychiatry, and Neurosurgery
Publisher: SPRINGERISSN: 1687-8329Frequency: 1 issue/year

Egyptian Journal of Neurology Psychiatry and Neurosurgery, published by Springer, is a premier open-access journal that has been dedicated to advancing the fields of neurology, psychiatry, and neurosurgery since its inception in 2009. With an E-ISSN of 1687-8329, this journal aims to provide a dynamic platform for researchers and clinicians to disseminate their findings, fostering a rich dialogue on the latest developments and innovations within these critical disciplines. With an impactful open-access model adopted since 2018, the journal attracts a global audience, facilitating the exchange of knowledge and ideas across various medical and scientific landscapes. In the 2023 rankings, it holds impressive positions within the Q3 category for Neurology (clinical), Psychiatry and Mental Health, and Surgery, as well as Q4 in Miscellaneous Neuroscience, highlighting its value within the field. As a valuable resource for both budding scholars and seasoned professionals, the Egyptian Journal of Neurology Psychiatry and Neurosurgery offers insights that drive progress in the treatment and understanding of neurological and psychiatric conditions.